Literature DB >> 20942595

Antineuronal antibodies in migraine patients with white matter lesions.

Recai Türkoğlu1, Erdem Tüzün, Sema Içöz, Omer Birişik, Ece Erdağ, Murat Kürtüncü, Gulsen Akman-Demir.   

Abstract

Magnetic resonance imaging (MRI) studies occasionally display focal hyperintense lesions within the white matter of migraine patients. No immunological factors associated with these lesions have been defined so far. To investigate the relationship between MRI lesions and antineuronal antibody response, 17 migraine patients with white matter lesions (WML), 19 migraine patients without WML, 20 multiple sclerosis patients with WML and with no headache history, and 20 healthy individuals were enrolled, and their sera were examined by indirect immunohistochemistry for the presence of immunoglobulin G (IgG) reacting with the rat brain tissue. Migraine patients with and without WML essentially showed identical demographic and clinical features and frequencies of systemic autoantibodies. However, migraine patients with WML displayed a significantly higher frequency of antineuronal antibodies than those without WML (12/17 vs. 2/19, p = .0004). Serum IgG of migraine patients predominantly reacted with the cytoplasm of neurons and the molecular layer of cerebellum. None of the multiple sclerosis patients and healthy controls displayed antineuronal antibodies. Our results imply the involvement of inflammation in migraine pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20942595     DOI: 10.3109/00207454.2010.524331

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  2 in total

Review 1.  Why do migraines often decrease as we age?

Authors:  Frederick G Freitag
Journal:  Curr Pain Headache Rep       Date:  2013-10

2.  White matter lesions in chronic migraine with medication overuse headache: a cross-sectional MRI study.

Authors:  Zhenyang Zheng; Zijian Xiao; Xiaolei Shi; Minghui Ding; Wei Di; Weiwei Qi; Aiwu Zhang; Yannan Fang
Journal:  J Neurol       Date:  2014-02-18       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.